Trademark: 85058102
Status Date
Tuesday, February 15, 2011
Filing Date
Wednesday, June 9, 2010
Abandoned Date
Monday, February 14, 2011
42 Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen
Feb 15, 2011
Abandonment Notice Mailed - Express Abandonment
Feb 15, 2011
Abandonment - Express Mailed
Feb 14, 2011
Teas Express Abandonment Received
Aug 27, 2010
Notification Of Letter Of Suspension E-Mailed
Aug 27, 2010
Letter Of Suspension E-Mailed
Aug 27, 2010
Suspension Letter Written
Aug 19, 2010
Teas/Email Correspondence Entered
Aug 19, 2010
Correspondence Received In Law Office
Aug 19, 2010
Teas Response To Suspension Inquiry Received
Aug 18, 2010
Amendment To Use Processing Complete
Aug 18, 2010
Use Amendment Filed
Aug 17, 2010
Teas Amendment Of Use Received
Jul 14, 2010
Notification Of Letter Of Suspension E-Mailed
Jul 14, 2010
Letter Of Suspension E-Mailed
Jul 14, 2010
Suspension Letter Written
Jul 12, 2010
Assigned To Examiner
Jun 14, 2010
New Application Office Supplied Data Entered In Tram
Jun 12, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
